HIV testing is a crucial step in protecting individual and public health. Early detection allows for timely treatment, improving long-term health outcomes and reducing the risk of transmission. Many people with HIV may not experience symptoms for years, making regular testing essential for early diagnosis.
Launch Diagnostics Ltd offer products for HIV screening, confirmation and typing:
For further information please visit the relevant webpages, email us at contact@launchdiagnostics.com or speak to your local territory manager.
Line immunoassay for the confirmation and discrimination of antibodies to HIV-1, HIV-1 group O and HIV-2 in human serum and plasma
An EIA for the qualitative detection of HIV p24 antigen in human serum, plasma, and cell culture supernatant. Protocol for RUO quantification of p24 antigen
TENDIGO simplifies your work with INNO-LIA® and INNO-LIPA® assays TENDIGO turns daily manual work into automation for low throughput testing volumes. Validated INNO-LIA and...
